CD74-dependent deregulation of the tumor suppressor scribble in human epithelial and breast cancer cells

Neoplasia (United States)

Volumn 15, Issue 6, 2013, Pages 660-668

  Metodieva, Gergana ^a   Nogueira de Souza, Naiara Correa ^a   Greenwood, Christina ^b   Al Janabi, Khalid ^c   Leng, Lin ^d   Bucala, Richard ^d   Metodiev, Metodi V ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

^b ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^c BROOMFIELD HOSPITAL   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD74 ANTIGEN; MEMBRANE PROTEIN; PHOSPHOPEPTIDE; TETRACYCLINE;

ARTICLE; BIOPSY; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CELL ADHESION; CELL CONTACT; CELL CULTURE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTON TRANSPORT; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TRANSIENT TRANSFECTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

EID: 84878661687     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.13464     Document Type: Article

References (26)

1. Burton JD, Ely S, Reddy PK, Stein R, Gold DV, Cardillo TM, and Goldenberg DM (2004). CD74 is expressed by multiple myeloma and is a promising target for therapy. Clin Cancer Res 10, 6606-6611.
2. Gold DV, Stein R, Burton J, and Goldenberg DM (2010). Enhanced expression of CD74 in gastrointestinal cancers and benign tissues. Int J Clin Exp Pathol 4, 1-12.
3. Sapra P, Stein R, Pickett J, Qu Z, Govindan SV, Cardillo TM, Hansen HJ, Horak ID, Griffiths GL, and Goldenberg DM (2005). Anti-CD74 antibodydoxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys. Clin Cancer Res 11, 5257-5264.
4. Leth-Larsen R, Lund RR, and Ditzel HJ (2010). Plasma membrane proteomics and its application in clinical cancer biomarker discovery. Mol Cell Proteomics 9, 1369-1382.
5. Greenwood C, Metodieva G, Al-Janabi K, Lausen B, Alldridge L, Leng L, Bucala R, Fernandez N, and Metodiev MV (2012). Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer. J Proteomics 75, 3031-3040.
6. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, and Bucala R (2003). MIF signal transduction initiated by binding to CD74. J Exp Med 197, 1467-1476.
7. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, and Bernhagen J (2006). Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal 18, 688-703.
8. Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E, et al. (2006). CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25, 595-606.
9. Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB, Allred C, and Muthuswamy SK (2008). Deregulation of Scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 135, 865-878.
10. Bilder D and Perrimon N (2000). Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature 403, 676-680.
11. Bilder D, Li M, and Perrimon N (2000). Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science 289, 113-116.
12. Qin Y, Capaldo C, Gumbiner BM, and Macara IG (2005). The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 171, 1061-1071.
13. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, and Mann M (2002). Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1, 376-386.
14. Reeves PJ, Thurmond RL, and Khorana HG (1996). Structure and function in rhodopsin: high level expression of a synthetic bovine opsin gene and its mutants in stable mammalian cell lines. Proc Natl Acad Sci USA 93, 11487-11492.
15. Alldridge L, Metodieva G, Greenwood C, Al-Janabi K, Thwaites L, Sauven P, and Metodiev M (2008). Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry. J Proteome Res 7, 1458-1469.
16. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, and Mann M (2011). Andromeda: a peptide search engine integrated into the MaxQuant environment. J Proteome Res 10, 1794-1805.
17. Luber CA, Cox J, Lauterbach H, Fancke B, Selbach M, Tschopp J, Akira S, Wiegand M, Hochrein H, O'Keeffe M, et al. (2010). Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32, 279-289.
18. Cox J and Mann M (2008). MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26, 1367-1372.
19. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, and Mann M (2006). Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127, 635-648.
20. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villen J, Li J, Cohn MA, Cantley LC, and Gygi SP (2004). Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci USA 101, 12130-12135.
21. Blagoev B, Kratchmarova I, Ong SE, Nielsen M, Foster LJ, and Mann M (2003). A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 21, 315-318.
22. Bilder D (2004). Epithelial polarity and proliferation control: links from the Drosophila neoplastic tumor suppressors. Genes Dev 18, 1909-1925.
23. Bilder D, Schober M, and Perrimon N (2003). Integrated activity of PDZ protein complexes regulates epithelial polarity. Nat Cell Biol 5, 53-58.
24. Nagasaka K, Massimi P, Pim D, Subbaiah VK, Kranjec C, Nakagawa S, Yano T, Taketani Y, and Banks L (2010). The mechanism and implications of hScrib regulation of ERK. Small GTPases 1, 108-112.
25. Nagasaka K, Pim D, Massimi P, Thomas M, Tomaic V, Subbaiah VK, Kranjec C, Nakagawa S, Yano T, Taketani Y, et al. (2010). The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction. Oncogene 29, 5311-5321.
26. Nagasaka K, Nakagawa S, Yano T, Takizawa S, Matsumoto Y, Tsuruga T, Nakagawa K, Minaguchi T, Oda K, Hiraike-Wada O, et al. (2006). Human homolog of Drosophila tumor suppressor Scribble negatively regulates cell-cycle progression from G1 to S phase by localizing at the basolateral membrane in epithelial cells. Cancer Sci 97, 1217-1225.